CD4 and COVID-19: While no such genes were identified consistently across both study stages, GSEA on the stage 2 data revealed several B cell-related pathways and simulated CD4 T cell pathways that were exclusively enriched in ChAdOx1 nCoV-19 vaccinees at onset of COVID-19 (Fig. 6d).